What is the expected growth forecast for the Laser BPH Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Laser BPH Devices market?

Increasing demand for minimally invasive procedures drives the market.

What challenges does the Laser BPH Devices market face?

High costs and limited awareness hinder market growth.

Which regions lead the Laser BPH Devices market?

North America and Europe are the leading regions.

Who are the top companies in the Laser BPH Devices market?

Leading companies include Medtronic and Boston Scientific.

What future opportunities exist in the Laser BPH Devices market?

Emerging markets and technological advancements offer growth opportunities.

How does technology impact the Laser BPH Devices market future outlook?

Advances in laser technology improve treatment outcomes and drive adoption.

What is the current regulatory landscape for Laser BPH Devices?

Stringent regulations and clearance requirements apply to new devices.

How will the Laser BPH Devices market size change in the next 5 years?

The market is expected to reach USD 1.8 billion by 2028.

Laser Benign Prostatic Hyperplasia (BPH) Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

Laser Benign Prostatic Hyperplasia (BPH) Devices by Type (Fixed, Trolley Mounted, World Laser Benign Prostatic Hyperplasia (BPH) Devices Production), by Application (Ambulatory Surgical Centres (ASC), Urology Centre, Hospitals, Speciality Clinics, Others, World Laser Benign Prostatic Hyperplasia (BPH) Devices Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Laser Benign Prostatic Hyperplasia (BPH) Devices Market Overview

The Laser Benign Prostatic Hyperplasia (BPH) Devices market refers to the industry that provides medical devices used to treat Benign Prostatic Hyperplasia (BPH), a common condition in older men. The Laser BPH Devices market size is estimated to be around $1.3 billion in 2025, with a growth outlook that is expected to drive the market forecast to reach $2.5 billion by 2033, at a CAGR of 7.5%. This industry expansion is largely driven by the increasing prevalence of BPH, advancements in laser technology, and rising demand for minimally invasive treatments. The scope of this market includes various types of laser devices, such as holmium laser, thulium laser, and diode laser, used in hospitals, clinics, and urology centers.

Loading chart…

The growth forecast of the Laser BPH Devices market is driven by macro drivers such as the increasing aging population, rising healthcare expenditure, and advancements in medical technology. Key forces shaping the industry include technology shifts towards more advanced laser systems, regulations and guidelines set by government agencies, and changing consumer behavior towards minimally invasive treatments. The largest region for the Laser BPH Devices market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for advanced medical treatments and improving healthcare infrastructure. Overall, the Laser BPH Devices market is expected to experience significant growth over the forecast period, driven by the increasing demand for effective and minimally invasive treatments for BPH.

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	14.08 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Endo Pharmaceuticals; KARL STORZ; Lumenis; Olympus Winter; Urologix; Boston Scientific Corporation; LISA Laser; ProArc Medical; Urovision-Urotech; Teleflex Incorporated; Richard Wolf; BD; Biolitec; Coloplast Corp
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Laser Benign Prostatic Hyperplasia (BPH) Devices market is poised for significant growth, driven by an increasing prevalence of BPH and a growing demand for minimally invasive treatments. The Laser Benign Prostatic Hyperplasia (BPH) Devices market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advancements in laser technology have improved the efficacy and safety of BPH treatments, driving adoption rates and contributing to the Laser Benign Prostatic Hyperplasia (BPH) Devices market growth.

An aging population and rising incidence of BPH are fueling demand for effective treatment options, thereby boosting the Laser Benign Prostatic Hyperplasia (BPH) Devices market size.

Restraints2 items

High costs associated with laser BPH treatments and devices may limit adoption in price-sensitive markets, potentially hindering the Laser Benign Prostatic Hyperplasia (BPH) Devices market growth.

Stringent regulatory requirements and time-consuming approval processes may delay the introduction of new Laser Benign Prostatic Hyperplasia (BPH) Devices to the market, affecting the overall growth forecast.

Opportunities2 items

Emerging markets present significant opportunities for Laser Benign Prostatic Hyperplasia (BPH) Devices manufacturers, driven by increasing healthcare expenditure and a growing demand for advanced treatments.

Technological innovations, such as the development of more efficient and compact laser systems, can further enhance the Laser Benign Prostatic Hyperplasia (BPH) Devices market size and drive growth.

Challenges2 items

The Laser Benign Prostatic Hyperplasia (BPH) Devices market is highly competitive, with several established players, making it challenging for new entrants to gain market share and impact the growth forecast.

Post-operative complications and side effects associated with laser BPH treatments may affect patient outcomes and influence the overall perception of Laser Benign Prostatic Hyperplasia (BPH) Devices, potentially limiting market growth.

Market Segmentation

Loading chart…

The Laser Benign Prostatic Hyperplasia (BPH) Devices market can be segmented by type, which includes various laser-based technologies such as Holmium Laser Enucleation of the Prostate (HoLEP), Thulium Laser Enucleation of the Prostate (ThuLEP), and Diode Laser Enucleation of the Prostate (DiLEP). Each type contributes to the overall market size, with HoLEP being the most widely used due to its high efficacy and minimal side effects. Understanding the Laser Benign Prostatic Hyperplasia (BPH) Devices segmentation by type is crucial for manufacturers to develop targeted products and for healthcare providers to make informed decisions.

The Laser Benign Prostatic Hyperplasia (BPH) Devices market can also be segmented by application, which includes treatment of benign prostatic hyperplasia, prostate cancer, and other urological disorders. The treatment of benign prostatic hyperplasia is the largest application segment, accounting for the majority of the market share. This is due to the high prevalence of BPH among older men and the increasing demand for minimally invasive treatments. The market taxonomy of Laser BPH devices by application helps in identifying the most lucrative segments and developing strategies to tap into them.

Laser Benign Prostatic Hyperplasia (BPH) Devices Segmentation Breakdown11 items

Type

Fixed

Trolley Mounted

World Laser Benign Prostatic Hyperplasia (BPH) Devices Production

Application

Ambulatory Surgical Centres (ASC)

Urology Centre

Hospitals

Speciality Clinics

Others

World Laser Benign Prostatic Hyperplasia (BPH) Devices Production

Regional Insights

Loading chart…

The Laser Benign Prostatic Hyperplasia (BPH) Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of minimally invasive procedures, government policies supporting healthcare infrastructure development, and investments in medical technology.

Key drivers for each region include: North America - established healthcare infrastructure, high demand for BPH treatments, and technological advancements; Europe - rising prevalence of BPH, favorable reimbursement policies, and presence of key market players; Asia Pacific - growing demand for minimally invasive procedures, expanding healthcare infrastructure, and increasing awareness of BPH treatments; Latin America - improving economic conditions, investments in healthcare infrastructure, and growing demand for BPH treatments; Middle East & Africa - increasing healthcare spending, rising prevalence of BPH, and growing adoption of advanced medical technologies.

The regional forecast indicates a significant Laser Benign Prostatic Hyperplasia (BPH) Devices market growth in Asia Pacific, driven by demographic factors, infrastructure development, and ecosystem maturity. As the market continues to evolve, it is essential to monitor regional trends and developments to capitalize on emerging opportunities.

Competitive Landscape

The Laser Benign Prostatic Hyperplasia (BPH) Devices market is moderately consolidated, driven by a mix of global players and local/regional companies. The Laser Benign Prostatic Hyperplasia (BPH) Devices competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies are notable for their strategic focus:

Endo Pharmaceuticals: regional expansion

KARL STORZ: premium pricing

Lumenis: innovation pipeline

Olympus Winter: local manufacturing

Boston Scientific Corporation: OEM tie-ups

LISA Laser: vertical integration

Key Laser Benign Prostatic Hyperplasia (BPH) Devices Companies14 items

Endo Pharmaceuticals

KARL STORZ

Lumenis

Olympus Winter

Urologix

Boston Scientific Corporation

LISA Laser

ProArc Medical

Urovision-Urotech

Teleflex Incorporated

Richard Wolf

Biolitec

Coloplast Corp

Market Ecosystem

The Laser Benign Prostatic Hyperplasia (BPH) Devices ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of these devices, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The ecosystem boundaries are defined by the interactions between these segments, from raw material suppliers to end users, and the flow of value through the Laser Benign Prostatic Hyperplasia (BPH) Devices ecosystem.

Raw material/component suppliers — provide device components

OEMs / manufacturers — design and produce devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — distribute devices to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish device safety and efficacy standards

The flow of value through the ecosystem is influenced by various control points, such as regulatory approvals and reimbursement policies, which can impact the adoption of Laser BPH devices. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can influence the relationships between ecosystem participants. The ecosystem's dynamics can vary by region, with different regions having distinct regulatory environments, healthcare systems, and market requirements, highlighting the need for a nuanced understanding of the Laser Benign Prostatic Hyperplasia (BPH) Devices ecosystem through a detailed value chain analysis.

Recent Industry Insights

The Laser Benign Prostatic Hyperplasia (BPH) Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between medical device companies to enhance product offerings, have been a key highlight. Additionally, there have been notable mergers and acquisitions, including the acquisition of a leading laser technology firm to expand product portfolios. Furthermore, the introduction of advanced laser technologies has improved treatment outcomes, driving growth in the market.

Regulatory changes, such as the updated guidelines for laser device approvals, have also impacted the market. Moreover, a shift in consumer trends towards minimally invasive procedures has led to increased adoption of laser BPH devices. The market has also seen significant funding rounds, with investors backing innovative startups that are developing next-generation laser technologies. These developments are expected to continue shaping the Laser Benign Prostatic Hyperplasia (BPH) Devices industry trends in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Laser Benign Prostatic Hyperplasia (BPH) Devices market outlook. The market attractiveness is moderate, driven by an aging population and increasing prevalence of BPH. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with growing demand for minimally invasive treatments and advancements in laser technology.

The innovation landscape is dynamic, with ongoing research and development focused on improving treatment outcomes and reducing side effects. The demand-supply balance is expected to remain stable, with key risk factors including regulatory changes and reimbursement challenges. Overall, the Laser BPH Devices market is poised for growth, driven by technological advancements and increasing adoption of laser-based treatments.

12 items

1. Executive Summary

2. Laser Benign Prostatic Hyperplasia (BPH) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Competition by Key Manufacturers

9.1. Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Laser Benign Prostatic Hyperplasia (BPH) Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Endo Pharmaceuticals

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. KARL STORZ

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Lumenis

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Olympus Winter

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Urologix

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Boston Scientific Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LISA Laser

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ProArc Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Urovision-Urotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Teleflex Incorporated

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Richard Wolf

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. BD

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Biolitec

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Coloplast Corp

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market

Figure 4: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Drivers

Figure 5: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Challenges

Figure 6: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Trends

Figure 7: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Opportunity

Figure 8: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Restraint

Figure 9: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Value (USD Million) By Region

Figure 19: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Value (USD Million) By Region

Figure 27: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By: Regions (2032)

Figure 28: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) By Region

Figure 29: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Value (USD Million) By Region

Figure 37: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By: Regions (2032)

Figure 38: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) By Region

Figure 39: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Value (USD Million) By Region

Table 14: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) By Region

Table 31: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Endo Pharmaceuticals Basic Information And Sales Area

Table 52: Endo Pharmaceuticals. Products Portfolio

Table 53: KARL STORZ Basic Information And Sales Area

Table 54: KARL STORZ. Products Portfolio

Table 55: Lumenis Basic Information And Sales Area

Table 56: Lumenis. Products Portfolio

Table 57: Olympus Winter Basic Information And Sales Area

Table 58: Olympus Winter. Products Portfolio

Table 59: Urologix Basic Information And Sales Area

Table 60: Urologix. Products Portfolio

Table 61: Boston Scientific Corporation Basic Information And Sales Area

Table 62: Boston Scientific Corporation. Products Portfolio

Table 63: LISA Laser Basic Information And Sales Area

Table 64: LISA Laser. Products Portfolio

Table 65: ProArc Medical Basic Information And Sales Area

Table 66: ProArc Medical. Products Portfolio

Table 67: Urovision-Urotech Basic Information And Sales Area

Table 68: Urovision-Urotech. Products Portfolio

Table 69: Teleflex Incorporated Basic Information And Sales Area

Table 70: Teleflex Incorporated. Products Portfolio

Table 71: Richard Wolf Basic Information And Sales Area

Table 72: Richard Wolf. Products Portfolio

Table 73: BD Basic Information And Sales Area

Table 74: BD. Products Portfolio

Table 75: Biolitec Basic Information And Sales Area

Table 76: Biolitec. Products Portfolio

Table 77: Coloplast Corp Basic Information And Sales Area

Table 78: Coloplast Corp. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Value (USD Million) By Region

Table 88: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Volume (K) By Region

Table 105: Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Laser Benign Prostatic Hyperplasia (BPH) Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	14.08 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Endo Pharmaceuticals; KARL STORZ; Lumenis; Olympus Winter; Urologix; Boston Scientific Corporation; LISA Laser; ProArc Medical; Urovision-Urotech; Teleflex Incorporated; Richard Wolf; BD; Biolitec; Coloplast Corp
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

An aging population and rising incidence of BPH are fueling demand for effective treatment options, thereby boosting the Laser Benign Prostatic Hyperplasia (BPH) Devices market size.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Laser Benign Prostatic Hyperplasia (BPH) Devices Segmentation Breakdown11 items

Type

Fixed

Trolley Mounted

World Laser Benign Prostatic Hyperplasia (BPH) Devices Production

Application

Ambulatory Surgical Centres (ASC)

Urology Centre

Hospitals

Speciality Clinics

Others

World Laser Benign Prostatic Hyperplasia (BPH) Devices Production

Regional Insights

Loading chart…

Competitive Landscape

Endo Pharmaceuticals: regional expansion

KARL STORZ: premium pricing

Lumenis: innovation pipeline

Olympus Winter: local manufacturing

Boston Scientific Corporation: OEM tie-ups

LISA Laser: vertical integration

Key Laser Benign Prostatic Hyperplasia (BPH) Devices Companies14 items

Endo Pharmaceuticals

KARL STORZ

Lumenis

Olympus Winter

Urologix

Boston Scientific Corporation

LISA Laser

ProArc Medical

Urovision-Urotech

Teleflex Incorporated

Richard Wolf

Biolitec

Coloplast Corp

Market Ecosystem

Raw material/component suppliers — provide device components

OEMs / manufacturers — design and produce devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — distribute devices to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish device safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents